AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7006581
Drug: Simultaneous timolol
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Simultaneous timolol treatment with epinephrine
Trial: 7006581
Drug: Timolol and
RxNorm normalized name: timolol and thiazides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol and epinephrine combined therapy
Trial: 30614289
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg) plus Myoinositol (600 mg) three times a day
Trial: 30614289
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg) three times a day
Trial: 28550080
Drug: Intensive phosphate
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive phosphate goal of 2.33‐4.66 mg/dl (0.75‐1.50 mmol/L)
Trial: 28550080
Drug: Liberalized target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberalized target of 6.20‐7.75 mg/dl (2.00‐2.50 mmol/L)
Trial: 25525835
Drug: Prebiotic mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prebiotic mixture (9 g of galactooligosaccharides [GOS] + 1 g of maltodextrins; daily for 5 days)
Trial: 23831050
Drug: ARP1 (15-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARP1 (15-30 mg/kg/day)
Trial: 21331949
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tryptophan (Trp) and arginine (Arg) in diet
Trial: 17942035
Drug: Melatonin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (3 mg/24 h)
Trial: 17942035
Drug: Sulpiride (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (50 mg/8 h) plus Melatonin (3 mg/24 h)
Trial: 17942035
Drug: Placebo (lactose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (lactose 50 mg/8 h)
Trial: 9651260
Drug: Intravenous heroin
RxNorm normalized name: heroin
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous heroin (median 480 mg daily) and health/psychosocial services
Trial: 9651260
Drug: Conventional drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drug treatment (usually methadone maintenance)
Trial: 26494444
Drug: Caffeine (CAF)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (CAF) 4.5 mg/kg
Trial: 18974711
Drug: Inspiratory Muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory Muscle Training (IMT) for 11 weeks, consisting of 30 inspiratory efforts performed twice a day
Trial: 16669849
Drug: Paroxetine (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (10-40 mg day-1)
Trial: 11111206
Drug: α1-blockers
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α1-blockers
Trial: 11111206
Drug: Anti-hypertensive α1-blockers
RxNorm normalized name: INVESTIGATIONAL ANTI-HYPERTENSIVE DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-hypertensive α1-blockers (terazosin and doxazosin)
Trial: 1280145
Drug: Conventional dressings
RxNorm normalized name: DRESSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dressings (petroleum jelly gauze, petroleum jelly gauze with antibiotics, silver sulphadiazine cream)
Trial: 3871597
Drug: Intermittent self‐administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent self‐administered therapy (single‐dose trimethoprim‐sulfamethoxazole)
Trial: 3871597
Drug: Patient-administered therapy
RxNorm normalized name: lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Patient-administered therapy with single-dose trimethoprim‐sulfamethoxazole
Trial: 24576793
Drug: Drospirenone-containing combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drospirenone-containing combined oral contraceptives (DRSP24d)
Trial: 24576793
Drug: Drospirenone-containing combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drospirenone-containing combined oral contraceptives (DRSP21d)
Trial: 24576793
Drug: Non-drospirenone oral
RxNorm normalized name: Drospirenone
DrugBank: Drospirenone (DB01395)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Non-drospirenone oral contraceptives (non-DRSP)
Trial: 24576793
Drug: Levonorgestrel-containing oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel-containing oral contraceptives (LNG)
Trial: 20146168
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone replacement therapy (GHRT)
Trial: 11144372
Drug: DTaP/HepB vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP/HepB vaccine used to reconstitute lyophilized PRP‐T vaccine administered as a single injection
Trial: 11144372
Drug: DTaP/HepB vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP/HepB vaccine and PRP‐T vaccine administered as two separate injections
Trial: 11144372
Drug: DTaP, HepB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP, HepB and PRP‐T vaccines administered as three separate injections
Trial: 11144372
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of Hib conjugate vaccine given at 11 to 15 months of age
Trial: 8330602
Drug: Morphine 50
RxNorm normalized name: MORPHINE 50MG/NALTREXONE 2MG SA CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 50 micrograms kg‐1 (n = 32)
Trial: 30834513
Drug: ATB‐346 (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATB‐346 (250 mg once daily)
Trial: 30834513
Drug: naproxen (550
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen (550 mg twice daily)
Trial: 29523571
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CBT) for 4-6 weeks
Trial: 22452807
Drug: Intravenous glucose-insulin-potassium
RxNorm normalized name: glucose / potassium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glucose-insulin-potassium (GIK)
Trial: 25335328
Drug: Jiangzhi Tongluo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jiangzhi Tongluo Soft Capsule (JTSC) combined with Atorvastatin Calcium Tablet (ACT)
Trial: 25335328
Drug: Atorvastatin Calcium
RxNorm normalized name: Atorvastatin Calcium
DrugBank: Atorvastatin (DB01076)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atorvastatin Calcium Tablet (ACT) alone
Trial: 19717477
Drug: Amoxicillin clavulanate
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin clavulanate (n = 212)
Trial: 16007327
Drug: Monthly ibandronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly ibandronate 50 mg/50 mg
Trial: 16007327
Drug: Monthly ibandronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly ibandronate 100 mg
Trial: 16007327
Drug: Monthly ibandronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly ibandronate 150 mg
Trial: 16007327
Drug: Daily ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily ibandronate 2.5 mg
Trial: 16007327
Drug: All monthly
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All monthly regimens
Trial: 16007327
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg and 150 mg monthly regimens
Trial: 12910557
Drug: Other NSAIDs
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other NSAIDs (regardless of dosage)
Trial: 8874334
Drug: Tamoxifen 30
RxNorm normalized name: tamoxifen 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 30 mg/d for 2 years plus 6 months of intravenous chemotherapy with cyclophosphamide, methotrexate, and fluorouracil (CMF)
Trial: 8164053
Drug: Tamoxifen 30
RxNorm normalized name: tamoxifen 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 30 mg/d for 2 years
Trial: 30517889
Drug: Active CPAP
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active CPAP treatment for 12 weeks
Trial: 15580472
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CT with transanal electrical stimulation
Trial: 15580472
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CT with perineal electrical stimulation
Trial: 7561442
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no herbal therapy)
Trial: 2161633
Drug: Thoracic radiotherapy
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic radiotherapy plus vindesine (3 mg/m2 weekly for 6 weeks)
Trial: 2161633
Drug: Vindesine alone
RxNorm normalized name: vindesine
DrugBank: Vindesine (DB00309)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vindesine alone (3 mg/m2 weekly for 6 weeks)
Trial: 30991718
Drug: Chokeberry juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chokeberry juice with high-dose polyphenols (1177.11 mg GAE)
Trial: 30991718
Drug: Chokeberry juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chokeberry juice with low-dose polyphenols (294.28 mg GAE)
Trial: 30991718
Drug: Chokeberry juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chokeberry juice (both doses)
Trial: 28532539
Drug: Paclitaxel combined
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel combined with platinum chemotherapy
Trial: 23727257
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2 IV Q3 weeks)
Trial: 23727257
Drug: Docetaxel +
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel + Vandetanib (100 mg PO daily)
Trial: 19389877
Drug: Dapoxetine 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapoxetine 120 mg
Trial: 19389877
Drug: Dapoxetine 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapoxetine 240 mg
Trial: 17498486
Drug: High-dose Astragalus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose Astragalus injection with cyclophosphamide (CTX)
Trial: 17635371
Drug: Peginterferon alpha-2a,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peginterferon alpha-2a, 180 microg once weekly
Trial: 17635371
Drug: Peginterferon alpha-2b,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peginterferon alpha-2b, 1.0 microg/kg once weekly
Trial: 28445888
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of inflammatory and psychosocial stress
Trial: 24521180
Drug: Community pharmacists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community pharmacists (inexperienced in medication review) after receiving 2-day training in medication review
Trial: 15811899
Drug: medicines organizer
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: medicines organizer (MO)
Trial: 8579878
Drug: 120‐hour continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120‐hour continuous infusion 5‐Fu and bolus cisplatin
Trial: 2116667
Drug: Thromboembolism prophylaxis
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thromboembolism prophylaxis with heparin
Trial: 28873075
Drug: Magnesium infusion
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium infusion (30 mg/kg in the first hour followed by 9 mg/kg/h until the end of the surgical procedure)
Trial: 23523255
Drug: Protocolised treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocolised treatment (control)
Trial: 18157018
Drug: Propofol (5.7±0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (5.7±0.2 mg/kg/h)
Trial: 10333200
Drug: Budesonide (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (3 x 1 mg oral pH‐modified release)
Trial: 28575774
Drug: Manual-based psychosocial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual-based psychosocial group intervention (6 weekly 2-hour sessions)
Trial: 20843236
Drug: 0.4% moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4% moxifloxacin gel
Trial: 20843236
Drug: 1.25% moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25% moxifloxacin gel
Trial: 20843236
Drug: 0.125% moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125% moxifloxacin gel
Trial: 11303414
Drug: Emedastine 0.05%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emedastine 0.05% twice daily for 42 days
Trial: 11303414
Drug: Levocabastine 0.05%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levocabastine 0.05% twice daily for 42 days
Trial: 9247526
Drug: Amiodarone (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (800 mg/day for 14 days, 400 mg/day for 50 weeks, then 300 mg/day thereafter)
Trial: 8273226
Drug: Preincisional lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preincisional lidocaine infiltration (1% lidocaine, 40 ml)
Trial: 8273226
Drug: Postincisional lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postincisional lidocaine infiltration (1% lidocaine, 40 ml)
Trial: 3542342
Drug: L-adrenaline infusion
RxNorm normalized name: L-Adrenaline
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-adrenaline infusion
Trial: 3542342
Drug: Salbutamol infusion
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol infusion
Trial: 27842939
Drug: High-dose baclofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose baclofen (up to 150mg)
Trial: 27842939
Drug: Low-dose baclofen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose baclofen (30mg)
Trial: 22608583
Drug: Sugammadex (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex (both doses)
Trial: 14716113
Drug: Radiation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation treatment (Control)
Trial: 8642232
Drug: Enalaprilat (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalaprilat (2 mg)
Trial: 27631987
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection by physiotherapist
Trial: 27631987
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection by orthopaedic surgeon
Trial: 21148046
Drug: Honey (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honey (2 × 20 g/d)
Trial: 21148046
Drug: Artificial honey
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial honey (2 × 20 g/d)
Trial: 15273582
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole with paper diary
Trial: 15273582
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole with PDA
Trial: 11520717
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF-DPI) 50 microg, twice daily
Trial: 11520717
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF-DPI) 100 microg, twice daily
Trial: 11520717
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF-DPI) 400 microg, twice daily
Trial: 3042932
Drug: Detailed discussion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Detailed discussion with the patient's physician about decision making and life support therapy in the event of extreme or incapacitating illness.
Trial: 30653978
Drug: No Metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Metformin therapy
Trial: 11855540
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole at 08:00 hr followed by placebo
Trial: 11855540
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg ranitidine at 22:00 hr
Trial: 11855540
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole at 22:00 hr
Trial: 9665596
Drug: Riluzole 50
RxNorm normalized name: riluzole 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riluzole 50 mg bid for 3 weeks
Trial: 7647826
Drug: Plantago ovata
RxNorm normalized name: Plantago ovata seed
DrugBank: Plantago ovata seed (DB14585)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plantago ovata preparation (20 g granules with 200 ml water)
Trial: 7647826
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 g granules with 200 ml water)
Trial: 325342
Drug: delta9-tetrahydrocannabinol (THC)
RxNorm normalized name: delta9-tetrahydrocannabinol
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: delta9-tetrahydrocannabinol (THC) 15 MG/70 KG
Trial: 325342
Drug: Ethanol 0-54
RxNorm normalized name: ethanol 0.66 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 0-54 g/kg
Trial: 325342
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of THC and Ethanol
Trial: 29993259
Drug: Jidabokuippo (JDI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jidabokuippo (JDI) 7.5 g
Trial: 12627404
Drug: Various doses
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various doses of a drug
Trial: 2006742
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of 0.25% bupivacaine at 0.125 mL.kg‐1.h‐1 (n = 13)
Trial: 2006742
Drug: Repeated bolus
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated bolus injections of 0.5% bupivacaine with epinephrine 1:200,000 at 0.4 mL/kg every sixth hour (n = 12)
Trial: 26297325
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (0.3 g kg(‐1))
Trial: 26297325
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (0.2 g kg(‐1))
Trial: 22002790
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (random administration of the same tone)
Trial: 20080034
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) group: loading dose of selenium as selenite 15.18 micromol over 2 h and thereafter 10.12 micromol/d as a continuous intravenous infusion (CIV) for 10 d
Trial: 20080034
Drug: Very-high-dose (VHD)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very-high-dose (VHD) group: loading dose of 25.30 micromol over 2 h and thereafter 20.24 micromol as a CIV for 10 d
Trial: 16126048
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no feed supplements)
Trial: 12385860
Drug: Estradiol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (2 mg) for 28 days
Trial: 12385860
Drug: Estradiol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (2 mg) for 14 days and dydrogesterone (10 mg) for 14 days
Trial: 8077707
Drug: HBV vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBV vaccine containing 10 micrograms of S
Trial: 8077707
Drug: PreS2 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PreS2 + S vaccines (2 + 10 micrograms, 4 + 20 micrograms, or 8 + 40 micrograms)
Trial: 2809024
Drug: Immunotherapy (IT)
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (IT) with MC extract
Trial: 30327875
Drug: Eradication therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication therapy for H. pylori-positive gastric low-grade MALT lymphoma
Trial: 30327875
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy with 25.2 Gy
Trial: 30327875
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy with 36 Gy